Skip to main content
Veterinary Medicines

Api-Bioxal 44.2 mg/ml bee-hive solution

Authorised
  • Oxalic acid

Product identification

Medicine name:
Api-Bioxal 44.2 mg/ml bee-hive solution
API-BIOXAL 62 mg/ml SOLUCION PARA COLMENAS
Active substance:
  • Oxalic acid
Target species:
  • Honey bee
Route of administration:
  • In-hive use

Product details

Active substance and strength:
  • Oxalic acid
    44.20
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Bee-hive solution
Withdrawal period by route of administration:
  • In-hive use
    • Honey bee
      • Honey
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AG03
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:
  • 5 Lt bag-in-box container: opaque low-density polyethylene container in a cardboard box, bag-in-box (Ecopack) with screw cap (HDPE) and tamper-evident seal
  • 5 Lt container: white opaque high-density polyethylene cans, with screw cap (HDPE) and tamper-evident seal
  • 500 ml bottle: white opaque high-density polyethylene bottles with child – resistant screw cap (HDPE) and tamper-evident seal

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chemicals Laif S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chemifarma - S.p.A.
Responsible authority:
  • Spanish Agency For Medicines And Medical Devices
Authorisation number:
  • 4045 ESP
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0132/002
Concerned member states:
  • Austria
  • Bulgaria
  • Croatia
  • Ireland
  • Norway
  • Portugal
  • Romania
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 11/11/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."